Figure 1.

Neutralising activity in the peripheral blood of SOT recipients after two doses of a COVID‐19 mRNA vaccine. Neutralising activity of vaccine‐induced anti‐RBD antibodies in the peripheral blood of SOT recipients (N = 53) and healthy controls (N = 5; blue bars) after the second dose of the vaccine was measured as the degree of inhibition of RBD‐ACE2 interactions. Green, orange and red bars indicate different degrees of inhibition as indicated in the legend.